{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:06:34Z","timestamp":1789056394461,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018694","name":"European Commission Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF20SA0066621"],"award-info":[{"award-number":["NNF20SA0066621"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF20CC0035580"],"award-info":[{"award-number":["NNF20CC0035580"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omta.2026.201771","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:11:08Z","timestamp":1780935068000},"page":"201771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Omics-guided engineering of CHO cells reveals host targets to support AAV production"],"prefix":"10.1016","volume":"34","author":[{"given":"Konstantina","family":"Tzimou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillem","family":"L\u00f3pez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem Irem","family":"Sipahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars K.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9993-6332","authenticated-orcid":false,"given":"Jes\u00fas","family":"Lavado-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201771_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2024.108370","article-title":"Unravelling the essential elements for recombinant adeno-associated virus (rAAV) production in animal cell-based platforms","volume":"73","author":"Catal\u00e1n-Tatjer","year":"2024","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.omta.2026.201771_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2022.108017","article-title":"The cell density effect in animal cell-based bioprocessing: Questions, insights and perspectives","volume":"60","author":"Lavado-Garc\u00eda","year":"2022","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.omta.2026.201771_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101230","article-title":"Producing high-quantity and high-quality recombinant adeno-associated virus by low-cis triple transfection","volume":"32","author":"Liu","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201771_bib4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.omtm.2023.05.004","article-title":"A novel dual-plasmid platform provides scalable transfection yielding improved productivity and packaging across multiple AAV serotypes and genomes","volume":"29","author":"van Lieshout","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201771_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.omtm.2023.06.010","article-title":"Goody two plasmids: An optimized transient transfection system for AAV vector production","volume":"30","author":"Moreno Velasquez","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201771_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102563","article-title":"AAVone: A cost-effective, single-plasmid solution for efficient AAV production with reduced DNA impurities","volume":"36","author":"Yang","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omta.2026.201771_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.796991","article-title":"HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors","volume":"9","author":"Tan","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.omta.2026.201771_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jviromet.2013.10.038","article-title":"Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery","volume":"196","author":"Chahal","year":"2014","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.omta.2026.201771_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0065-3527(06)68008-1","article-title":"Baculovirus Vectors for Gene Therapy","volume":"68","author":"Hu","year":"2006","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.omta.2026.201771_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41434-018-0034-7","article-title":"Optimization of viral protein ratios for production of rAAV serotype 5 in the baculovirus system","volume":"25","author":"Bosma","year":"2018","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201771_bib11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2174\/1570163817666200312102137","article-title":"A Review on the Current Methods of Chinese Hamster Ovary (CHO) Cells Cultivation for the Production of Therapeutic Protein","volume":"18","author":"Sharker","year":"2021","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.omta.2026.201771_bib12","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00253-011-3758-5","article-title":"CHO cells in biotechnology for production of recombinant proteins: current state and further potential","volume":"93","author":"Kim","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.omta.2026.201771_bib13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00253-012-4451-z","article-title":"Recent advances in technology supporting biopharmaceutical production from mammalian cells","volume":"96","author":"Butler","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.omta.2026.201771_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46298-3","article-title":"Engineered CHO cells as a novel AAV production platform for gene therapy delivery","volume":"13","author":"Nagy","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omta.2026.201771_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/bit.28578","article-title":"Recombinant adeno-associated virus production evaluation in Chinese hamster ovary cells","volume":"121","author":"Cao","year":"2024","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.omta.2026.201771_bib16","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/bit.25227","article-title":"Synthetic promoters for CHO cell engineering","volume":"111","author":"Brown","year":"2014","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.omta.2026.201771_bib17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/ars.2012.4938","article-title":"New Insights into the Link Between DNA Damage and Apoptosis","volume":"19","author":"De Zio","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.omta.2026.201771_bib18","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.molmed.2006.07.007","article-title":"DNA damage-induced cell death by apoptosis","volume":"12","author":"Roos","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omta.2026.201771_bib19","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/cdd.2010.58","article-title":"Cracking the death code: apoptosis-related histone modifications","volume":"17","author":"F\u00fcllgrabe","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.omta.2026.201771_bib20","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1128\/JVI.74.20.9441-9450.2000","article-title":"Adeno-Associated Virus Type 2 Rep78 Induces Apoptosis through Caspase Activation Independently of p53","volume":"74","author":"Schmidt","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201771_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202400529","article-title":"Knockout of Pro-Apoptotic BAX and BAK1 Genes in HEK293T Cells Enhances Adeno-Associated Virus (AAV) Production: AAV2 and AAV9","volume":"20","author":"Park","year":"2025","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.omta.2026.201771_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202400501","article-title":"Unraveling Cytotoxicity in HEK293 Cells During Recombinant AAV Production for Gene Therapy Applications","volume":"20","author":"Ladiwala","year":"2025","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.omta.2026.201771_bib23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/pro.2625","article-title":"Role of membrane contact sites in protein import into mitochondria","volume":"24","author":"Horvath","year":"2015","journal-title":"Protein Sci."},{"key":"10.1016\/j.omta.2026.201771_bib24","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev-biochem-060815-014352","article-title":"Mitochondrial Machineries for Protein Import and Assembly","volume":"86","author":"Wiedemann","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.omta.2026.201771_bib25","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1099\/vir.0.043232-0","article-title":"Nuclear translocation of adeno-associated virus type 2 capsid proteins for virion assembly","volume":"93","author":"Popa-Wagner","year":"2012","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.omta.2026.201771_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2217\/fvl-2017-0011","article-title":"Understanding Capsid Assembly and Genome Packaging for Adeno-Associated Viruses","volume":"12","author":"Bennett","year":"2017","journal-title":"Future Virol."},{"key":"10.1016\/j.omta.2026.201771_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01681-24","article-title":"Adeno-associated virus 9 (AAV9) viral proteins VP1, VP2, and membrane-associated accessory protein (MAAP) differentially influence in vivo transgene expression","volume":"98","author":"Powell","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201771_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2232","article-title":"Mitochondrial changes associated with viral infectious diseases in the paediatric population","volume":"31","author":"Romero-Cordero","year":"2021","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.omta.2026.201771_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009841","article-title":"Downregulation of mitochondrial biogenesis by virus infection triggers antiviral responses by cyclic GMP-AMP synthase","volume":"17","author":"Sato","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omta.2026.201771_bib30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/life11030232","article-title":"Role of Mitochondria in Viral Infections","volume":"11","author":"Elesela","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.omta.2026.201771_bib31","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1038\/s41467-019-11164-2","article-title":"Activation of NIX-mediated mitophagy by an interferon regulatory factor homologue of human herpesvirus","volume":"10","author":"Vo","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201771_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011170","article-title":"Antagonism of ALAS1 by the Measles Virus V protein contributes to degradation of the mitochondrial network and promotes interferon response","volume":"19","author":"Khalfi","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omta.2026.201771_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011829","article-title":"Progression of herpesvirus infection remodels mitochondrial organization and metabolism","volume":"20","author":"Leclerc","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omta.2026.201771_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101384","article-title":"Transcriptomics-informed pharmacology identifies epigenetic and cell cycle regulators that enhance AAV production","volume":"32","author":"Tworig","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201771_bib35","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/v12060610","article-title":"Differential Effects of Human Adenovirus E1A Protein Isoforms on Aerobic Glycolysis in A549 Human Lung Epithelial Cells","volume":"12","author":"Prusinkiewicz","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.omta.2026.201771_bib36","article-title":"The Human Adenovirus Type 5 E4orf6\/E1B55K E3 Ubiquitin Ligase Complex Enhances E1A Functional Activity","volume":"1","author":"Dallaire","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.omta.2026.201771_bib37","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00253-024-13315-y","article-title":"Improvement strategies for transient gene expression in mammalian cells","volume":"108","author":"Fu","year":"2024","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.omta.2026.201771_bib38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40199-023-00477-9","article-title":"Comparison of different transient gene expression systems for the production of a new humanized anti-HER2 monoclonal antibody (Hersintuzumab)","volume":"31","author":"Roshani","year":"2023","journal-title":"Daru."},{"key":"10.1016\/j.omta.2026.201771_bib39","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3390\/pharmaceutics14091949","article-title":"Predicting Transiently Expressed Protein Yields: Comparison of Transfection Methods in CHO and HEK293","volume":"14","author":"Porosk","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omta.2026.201771_bib40","doi-asserted-by":"crossref","first-page":"18997","DOI":"10.1074\/jbc.270.32.18997","article-title":"Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid","volume":"270","author":"Zabner","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201771_bib41","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12542","article-title":"Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection","volume":"502","author":"Goujon","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201771_bib42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s007050170189","article-title":"Mouse Mx2 protein inhibits hantavirus but not influenza virus replication","volume":"146","author":"Jin","year":"2001","journal-title":"Arch. Virol."},{"key":"10.1016\/j.omta.2026.201771_bib43","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1128\/JVI.00214-14","article-title":"Host and Viral Determinants of Mx2 Antiretroviral Activity","volume":"88","author":"Busnadiego","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201771_bib44","doi-asserted-by":"crossref","first-page":"8957","DOI":"10.1073\/pnas.0403167101","article-title":"Inhibition of nuclear import and cell-cycle progression by mutated forms of the dynamin-like GTPase MxB","volume":"101","author":"King","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201771_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2023.194925","article-title":"The moonlighting of RAD23 in DNA repair and protein degradation","volume":"1866","author":"Gr\u00f8nb\u00e6k-Thygesen","year":"2023","journal-title":"Biochim. Biophys. Acta, Gene Regul. Mech."},{"key":"10.1016\/j.omta.2026.201771_bib46","article-title":"HIV-1 Replication through hHR23A-Mediated Interaction of Vpr with 26S Proteasome","volume":"5","author":"Li","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2026.201771_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101329","article-title":"Unlocking DOE potential by selecting the most appropriate design for rAAV optimization","volume":"32","author":"Tzimou","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201771_bib48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41434-025-00546-5","article-title":"Mixture design as a tool for improving full-to-empty particle ratios across various GOIs in rAAV production","volume":"33","author":"Tzimou","year":"2025","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201771_bib49","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/biot.201400388","article-title":"Designing cell lines for viral vaccine production: Where do we stand?","volume":"10","author":"Genzel","year":"2015","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.omta.2026.201771_bib50","doi-asserted-by":"crossref","first-page":"8725","DOI":"10.1007\/s00253-018-9275-z","article-title":"Process intensification of EB66\u00ae cell cultivations leads to high-yield yellow fever and Zika virus production","volume":"102","author":"Nikolay","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.omta.2026.201771_bib51","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1002\/bit.27470","article-title":"Virus harvesting in perfusion culture: Choosing the right type of hollow fiber membrane","volume":"117","author":"Nikolay","year":"2020","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.omta.2026.201771_bib52","author":"Andrews"},{"key":"10.1016\/j.omta.2026.201771_bib53","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201771_bib54","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s42003-020-0849-9","article-title":"Deep splicing plasticity of the human adenovirus type 5 transcriptome drives virus evolution","volume":"3","author":"Donovan-Banfield","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.omta.2026.201771_bib55","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omta.2026.201771_bib56","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nmeth.4324","article-title":"Differential analysis of RNA-seq incorporating quantification uncertainty","volume":"14","author":"Pimentel","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omta.2026.201771_bib57","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omta.2026.201771_bib58","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2","article-title":"Probability-based protein identification by searching sequence databases using mass spectrometry data","volume":"20","author":"Perkins","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1016\/j.omta.2026.201771_bib59","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1074\/mcp.M111.016469","article-title":"A Novel Strategy for Global Analysis of the Dynamic Thiol Redox Proteome","volume":"11","author":"Mart\u00ednez-Acedo","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.omta.2026.201771_bib60","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1021\/pr4006958","article-title":"General statistical framework for quantitative proteomics by stable isotope labeling","volume":"13","author":"Navarro","year":"2014","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.omta.2026.201771_bib61","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/bioinformatics\/bty815","article-title":"SanXoT: a modular and versatile package for the quantitative analysis of high-throughput proteomics experiments","volume":"35","author":"Trevisan-Herraz","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omta.2026.201771_bib62","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.csbj.2023.12.034","article-title":"iSanXoT: A standalone application for the integrative analysis of mass spectrometry-based quantitative proteomics data","volume":"23","author":"Rodr\u00edguez","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.omta.2026.201771_bib63","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1074\/mcp.M115.055905","article-title":"A Novel Systems-Biology Algorithm for the Analysis of Coordinated Protein Responses Using Quantitative Proteomics","volume":"15","author":"Garc\u00eda-Marqu\u00e9s","year":"2016","journal-title":"Mol. Cell. Proteomics"}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:11:44Z","timestamp":1789053104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26001060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3117387X26001060"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201771","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omics-guided engineering of CHO cells reveals host targets to support AAV production","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201771"}}